- KR₩303bn
- KR₩209bn
- KR₩204bn
- 82
- 63
- 60
- 80
Annual balance sheet for InBody Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 57,491 | 71,429 | 86,546 | 98,915 | 103,629 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,760 | 17,398 | 18,153 | 17,489 | 25,291 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 84,351 | 110,110 | 135,489 | 148,964 | 171,374 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 69,278 | 75,835 | 81,731 | 85,909 | 91,465 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 166,150 | 203,760 | 242,665 | 274,456 | 305,817 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 11,113 | 16,253 | 19,205 | 17,451 | 25,823 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 16,085 | 20,025 | 27,405 | 25,690 | 32,851 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 150,065 | 183,735 | 215,260 | 248,766 | 272,966 |
Total Liabilities & Shareholders' Equity | 166,150 | 203,760 | 242,665 | 274,456 | 305,817 |
Total Common Shares Outstanding |